SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Norris Medicines informs about outcome of directors meeting

22 Mar 2024 Evaluate
Norris Medicines has informed that Independent Directors of Norris Medicines, in their meeting commenced at 02:00 PM on 22nd March, 2024 have discussed the following; Reviewed the performance of Non-Independent Directors of the Company and the Board as a whole; Reviewed the performance of the Chairman of the Company taking into account the views of Executive Directors and Non-executive Directors; Assessed the quality, quantity and timeliness of flow of information between the Company management and the Board that is necessary for the Board to effectively and reasonable perform their duties.

The above information is a part of company’s filings submitted to BSE.

Norris Medicines Share Price

14.22 -0.02 (-0.14%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×